跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPAL SR tapentadol (as tartrate) 250 mg sustained release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TAPAL SR tapentadol (as tartrate) 250 mg sustained release tablet blister pack
Approved
STANDARD
TAPAL SR tapentadol (as tartrate) 250 mg sustained release tablet blister pack
Seed Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 12, 2026
Approval ID
12bd8ab958811fb3
Company
Seed Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
12bd8ab958811fb3
Product Name
TAPAL SR tapentadol (as tartrate) 250 mg sustained release tablet blister pack
Artg Id
476709
Artg Name
TAPAL SR tapentadol (as tartrate) 250 mg sustained release tablet blister pack
Sponsor
Seed Pharma Pty Ltd
Artg Date
2026-05-11
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 12, 2026
Approval ID
12bd8ab958811fb3
Type
Standard
Back to TGA Approvals
